Clinical Trials
24
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
A Study to Evaluate Safety of ASC40 Tablets in Patients with Moderate to Severe Acne Vulgaris
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT06248008
- Locations
- 🇨🇳
Huashan Hospital Fudan University, Shanghai, Shanghai, China
A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2025-06-19
- Lead Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 480
- Registration Number
- NCT06192264
- Locations
- 🇨🇳
The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China
🇨🇳The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China
Study to Evaluate Safety, Tolerability, PK and the Food Effect on PK of ASC11/RTV Tablets in Healthy Subjects
- Conditions
- HealthyCOVID-19
- Interventions
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT05718518
- Locations
- 🇨🇳
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT05596045
- Locations
- 🇺🇸
Pinnacle Research Group, Anniston, Alabama, United States
🇺🇸Aga Clinical Trials, Hialeah, Florida, United States
Study to Evaluate Safety, Tolerability, Pharmacokinetics and the Food Effect on PK of ASC10 Tablets in Healthy Subjects
- First Posted Date
- 2022-08-31
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT05523141
- Locations
- 🇨🇳
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
- Prev
- 1
- 2
- 3
- 4
- 5
- Next